Registro:

Referencias:

• Black, D.L., Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology (2000) Cell, 103, pp. 367-370
• Graveley, B.R., Alternative splicing: Increasing diversity in the proteomic world (2001) Trends Genet., 17, pp. 100-107
• Kramer, A., The structure and function of proteins involved in mammalian pre-mRNA splicing (1996) Annu. Rev. Biochem., 65, pp. 367-409
• Dreyfuss, G., hnRNP proteins and the biogenesis of mRNA (1993) Annu. Rev. Biochem., 62, pp. 289-321
• Smith, C.W., Valcarcel, J., Alternative pre-mRNA splicing: The logic of combinatorial control (2000) Trends Biochem. Sci., 25, pp. 381-388
• Berget, S.M., Exon recognition in vertebrate splicing (1995) J. Biol. Chem., 270, pp. 2411-2414
• Horowitz, D.S., Krainer, A.R., Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing (1994) Trends Genet., 10, pp. 100-106
• Fu, X.D., The superfamily of arginine/serine-rich splicing factors (1995) RNA, 1, pp. 663-680
• Graveley, B.R., Sorting out the complexity of SR protein functions (2000) RNA, 6, pp. 1197-1211
• Tacke, R., Manley, J.L., Determinants of SR protein specificity (1999) Curr. Opin. Cell Biol., 11, pp. 358-362
• Wu, J.Y., Maniatis, T., Specific interactions between proteins implicated in splice site selection and regulated alternative splicing (1993) Cell, 75, pp. 1061-1070
• Blencowe, B.J., Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases (2000) Trends Biochem. Sci., 25, pp. 106-110
• Mayeda, A., Krainer, A.R., Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2 (1992) Cell, 68, pp. 365-375
• Caceres, J.F., Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors (1994) Science, 265, pp. 1706-1709
• Yang, X., The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5′ splice site selection in vivo (1994) Proc. Natl. Acad. Sci. U. S. A., 91, pp. 6924-6928
• Gallego, M.E., The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A (1997) EMBO J., 16, pp. 1772-1784
• Jumaa, H., Nielsen, P.J., The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation (1997) EMBO J., 16, pp. 5077-5085
• Eperon, I.C., Selection of alternative 5′ splice sites: Role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1 (2000) Mol. Cell. Biol., 20, pp. 8303-8318
• Chabot, B., An intron element modulating 5′ splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1 (1997) Mol. Cell. Biol., 17, pp. 1776-1786
• Longman, D., Multiple interactions between SRm160 and SR family proteins in enhancer-dependent splicing and development of C. elegans (2001) Curr. Biol., 11, pp. 1923-1933
• Hastings, M.L., Krainer, A.R., Pre-mRNA splicing in the new millennium (2001) Curr. Opin. Cell Biol., 13, pp. 302-309
• Zhu, J., Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins (2001) Mol. Cell, 8, pp. 1351-1361
• Zahler, A.M., Distinct functions of SR proteins in alternative pre-mRNA splicing (1993) Science, 260, pp. 219-222
• Hanamura, A., Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors (1998) RNA, 4, pp. 430-444
• Wang, J., Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability (1996) Genes Dev., 10, pp. 2588-2599
• Jumaa, H., Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20 (1999) Curr. Biol., 9, pp. 899-902
• Wang, H.Y., SC35 plays a role in T cell development and alternative splicing of CD45 (2001) Mol. Cell, 7, pp. 331-342
• Ring, H.Z., Lis, J.T., The SR protein B52/SRp55 is essential for Drosophila development (1994) Mol. Cell. Biol., 14, pp. 7499-7506
• Peng, X., Mount, S.M., Genetic enhancement of RNA-processing defects by a dominant mutation in B52, the Drosophila gene for an SR protein splicing factor (1995) Mol. Cell. Biol., 15, pp. 6273-6282
• Hoffman, B.E., Lis, J.T., Pre-mRNA splicing by the essential Drosophila protein B52: Tissue and target specificity (2000) Mol. Cell. Biol., 20, pp. 181-186
• Longman, D., Functional characterization of SR and SR-related genes in Caenorhabditis elegans (2000) EMBO J., 19, pp. 1625-1637
• Kawano, T., Unique and redundant functions of SR proteins, a conserved family of splicing factors, in Caenorhabditis elegans development (2000) Mech. Dev., 95, pp. 67-76
• Valcarcel, J., Gebauer, F., Post-transcriptional regulation: The dawn of PTB (1997) Curr. Biol., 7, pp. R705-R708
• Wollerton, M.C., Differential alternative splicing activity of isoforms of polypyrimidine tract binding protein (PTB) (2001) RNA, 7, pp. 819-832
• Ladd, A.N., The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing (2001) Mol. Cell. Biol., 21, pp. 1285-1296
• Grabowski, P.J., Black, D.L., Alternative RNA splicing in the nervous system (2001) Prog. Neurobiol., 65, pp. 289-308
• Stamm, S., A sequence compilation and comparison of exons that are alternatively spliced in neurons (1994) Nucleic Acids Res., 22, pp. 1515-1526
• Jensen, K.B., Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability (2000) Neuron, 25, pp. 359-371
• Polydorides, A.D., A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing (2000) Proc. Natl. Acad. Sci. U. S. A., 97, pp. 6350-6355
• Markovtsov, V., Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein (2000) Mol. Cell. Biol., 20, pp. 7463-7479
• Bentley, D., Coupling RNA polymerase II transcription with pre-mRNA processing (1999) Curr. Opin. Cell Biol., 11, pp. 347-351
• Hirose, Y., Manley, J.L., RNA polymerase II and the integration of nuclear events (2000) Genes Dev., 14, pp. 1415-1429
• Proudfoot, N., Connecting transcription to messenger RNA processing (2000) Trends Biochem. Sci., 25, pp. 290-293
• Misteli, T., The dynamics of a pre-mRNA splicing factor in living cells (1997) Nature, 387, pp. 523-527
• Misteli, T., Spector, D.L., RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo (1999) Mol. Cell, 3, pp. 697-705
• McCracken, S., The C-terminal domain of RNA polymerase II couples mRNA processing to transcription (1997) Nature, 385, pp. 357-361
• Cramer, P., Functional association between promoter structure and transcript alternative splicing (1997) Proc. Natl. Acad. Sci. U. S. A., 94, pp. 11456-11460
• Cramer, P., Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer (1999) Mol. Cell, 4, pp. 251-258
• Ge, H., A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2 (1998) Mol. Cell, 2, pp. 751-759
• Lai, M.C., A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing (1999) J. Biol. Chem., 274, pp. 11832-11841
• Davies, R.C., WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes (1998) Genes Dev., 12, pp. 3217-3225
• Monsalve, M., Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1 (2000) Mol. Cell, 6, pp. 307-316
• Nayler, O., SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements (1998) Nucleic Acids Res., 26, pp. 3542-3549
• Morris, D.P., Greenleaf, A.L., The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II (2000) J. Biol. Chem., 275, pp. 39935-39943
• Myers, J.K., Phosphorylation of RNA polymerase II CTD fragments results in tight binding to the WW domain from the yeast prolyl isomerase Ess1 (2001) Biochemistry, 40, pp. 8479-8486
• Carty, S.M., Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II (2000) Proc. Natl. Acad. Sci. U. S. A., 97, pp. 9015-9020
• Yuryev, A., The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins (1996) Proc. Natl. Acad. Sci. U. S. A., 93, pp. 6975-6980
• Patturajan, M., A nuclear matrix protein interacts with the phosphorylated C-terminal domain of RNA polymerase II (1998) Mol. Cell. Biol., 18, pp. 2406-2415
• Kadener, S., Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing (2001) EMBO J., 20, pp. 5759-5768
• Eperon, L.P., Effects of RNA secondary structure on alternative splicing of pre-mRNA: Is folding limited to a region behind the transcribing RNA polymerase? (1988) Cell, 54, pp. 393-401
• Roberts, G.C., Co-transcriptional commitment to alternative splice site selection (1998) Nucleic Acids Res., 26, pp. 5568-5572
• Krawczak, M., The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences (1992) Hum. Genet., 90, pp. 41-54
• Maquat, L.E., Carmichael, G.G., Quality control of mRNA function (2001) Cell, 104, pp. 173-176
• Iborra, F.J., Coupled transcription and translation within nuclei of mammalian cells (2001) Science, 293, pp. 1139-1142
• Liu, H.X., A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes (2001) Nat. Genet., 27, pp. 55-58
• Buratti, E., Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping (2001) EMBO J., 20, pp. 1774-1784
• Philips, A.V., Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy (1998) Science, 280, pp. 737-741
• Savkur, R.S., Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy (2001) Nat. Genet., 29, pp. 40-47
• Llewellyn, D.H., Acute intermittent porphyria caused by defective splicing of porphobilinogen deaminase RNA: A synonymous codon mutation at -22 bp from the 5′ splice site causes skipping of exon 3 (1996) J. Med. Genet., 33, pp. 437-438
• Mazoyer, S., A BRCA1 nonsense mutation causes exon skipping (1998) Am. J. Hum. Genet., 62, pp. 713-715
• Vuillaumier-Barrot, S., Characterization of the 415G→A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping (1999) Hum. Mutat., 14, pp. 543-544
• Chen, W., Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5′ splice site at the mutant codon in cerebrotendinous xanthomatosis patients (1998) Biochemistry, 37, pp. 4420-4428
• Pousi, B., A nonsense codon of exon 14 reduces lysyl hydroxylase mRNA and leads to aberrant RNA splicing in a patient with Ehlers-Danlos syndrome type VI (2000) Mutat. Res., 432, pp. 33-37
• Yamada, T., Novel mutations of the FANCG gene causing alternative splicing in Japanese Fanconi anemia (2000) J. Hum. Genet., 45, pp. 159-166
• D'Souza, I., Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements (1999) Proc. Natl. Acad. Sci. U. S. A, 96, pp. 5598-5603
• Stanford, P.M., Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations (2000) Brain, 123, pp. 880-893
• De Meirleir, L., Aberrant splicing of exon 6 in the pyruvate dehydrogenase-E1 alpha mRNA linked to a silent mutation in a large family with Leigh's encephalomyelopathy (1994) Pediatr. Res., 36, pp. 707-712
• Liu, W., Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome (1997) Nat. Genet., 16, pp. 328-329
• Hasegawa, Y., Single exon mutation in arylsulfatase A gene has two effects: Loss of enzyme activity and aberrant splicing (1994) Hum. Genet., 93, pp. 415-420
• Ars, E., Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1 (2000) Hum. Mol. Genet., 9, pp. 237-247
• Matsuura, T., Identification of two new aberrant splicings in the ornithine carbamoyltransferase (OCT) gene in two patients with early and late onset OCT deficiency (1995) J. Inherit. Metab. Dis., 18, pp. 273-282
• Mendez, M., Familial porphyria cutanea tarda: Characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles (1998) Am. J. Hum. Genet., 63, pp. 1363-1375
• Wakamatsu, N., A novel exon mutation in the human β-hexosaminidase beta subunit gene affects 3′ splice site selection (1992) J. Biol. Chem., 267, pp. 2406-2413
• Santisteban, I., Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: Implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA (1995) Hum. Mol. Genet., 4, pp. 2081-2087
• Sossi, V., Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype (2001) Eur. J. Hum. Genet., 9, pp. 113-120
• Lorson, C.L., A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy (1999) Proc. Natl. Acad. Sci. U. S. A., 96, pp. 6307-6311
• Ploos van Amstel, J.K., Hereditary tyrosinemia type 1: Novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship (1996) Hum. Genet., 97, pp. 51-59
• Dreumont, N., A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation (2001) BMC Genet., 2, p. 9

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------